NCT03657836 is a NA clinical trial of Sublimated mare milk supplement in Acute Bronchitis, sponsored by Nazarbayev University Medical Center.

Who is sponsoring NCT03657836?

NCT03657836 is sponsored by Nazarbayev University Medical Center.

What drugs are being tested in NCT03657836?

Interventions in NCT03657836: Sublimated mare milk supplement, Standard antibiotic therapy.

What condition does NCT03657836 study?

NCT03657836 studies Acute Bronchitis.

Is NCT03657836 still recruiting?

NCT03657836 is currently completed. Last updated 8 February 2021.

Last reviewed 2021-02-08 · How we verify

NCT03657836

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics

Completed NA Last updated 8 February 2021

What this trial tests

NA trial testing Sublimated mare milk supplement in Acute Bronchitis in 12 participants. Completed in 1 December 2020.

Timeline

1 August 2018

Primary endpoint
20 January 2019

1 December 2020

Quick facts

Lead sponsor	Nazarbayev University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	1 August 2018
Primary completion	20 January 2019
Estimated completion	1 December 2020
Sites	1 location across Kazakhstan

Drugs / interventions tested

Sublimated mare milk supplement
Standard antibiotic therapy — full drug profile →

Conditions studied

Acute Bronchitis — all drugs for Acute Bronchitis →

Sponsor

Nazarbayev University Medical Center

Who can join

Adults 4 to 5, any sex, with Acute Bronchitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial studies the effect of sublimated mare milk supplement on gut microbiome of patients with acute bronchitis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Dynamic Changes in Microbiome Composition Following Mare's Milk Intake for Prevention of Collateral Antibiotic Effect.
Kushugulova A, Löber U, Akpanova S, Rysbekov K, et al · · 2021 · cited 6× · PMID 33968795 · DOI 10.3389/fcimb.2021.622735

Verify or expand the search:

Other recruiting trials for Acute Bronchitis

Currently open trials in the same condition.

NCT07359287 — Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care · NA · recruiting

Other Nazarbayev University Medical Center trials

Trials by the same sponsor.

NCT04833062 — The Influence of Advanced Age, Obesity and Diabetes Type on Course and Outcome of Pregnancy With Diabetes Mellitus. · not yet recruiting
NCT03594877 — Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03657836 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nazarbayev University Medical Center
Last refreshed: 8 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03657836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing